Ken W. Marshall - SVP, Chief Commercial Officer at Aquestive Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Commercial Officer
Stock Symbol
AQST on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ken W. Marshall since 4/23/2024

Holdings reported by Ken W. Marshall for Aquestive Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 150K $122K $0.81 Mar 9, 2023 Direct
Common Stock 1.45K $1.17K $0.81 Mar 9, 2023 Tasro Consulting, LLC 401(k) Plan, Kenneth Marshall Trustee, f/b/o Kenneth Marshall
Performance Stock Units 75K Aug 9, 2023 Direct Common Stock
Non-Qualified Stock Option (right to buy) 40K Nov 4, 2022 Direct Common Stock

Transactions reported by Ken W. Marshall for Aquestive Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.